Inhibikase Therapeutics Virtual KOL Investor Event

April 20, 2022

Watch The Replay

Targeted Therapies for Life-threatening Neurodegenerative Diseases

Our pipeline includes multiple products developed from our proprietary RAMP™ drug innovation and prodrug technology engines. Our programs are focused on halting and reversing the effects of neurodegenerative diseases inside and outside of the brain.  We are also developing host-targeted therapeutics for neurological infections in the brain.

Our Pipeline

Get Involved in Our Trials

For Patients